Stay updated on Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page.

Latest updates to the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added to the history. Notices about government funding and operating status were removed.SummaryDifference0.8%

- Check21 days agoChange DetectedA site-wide funding-status notice was added and the record history shows Revision v3.4.1, replacing Revision v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check28 days agoChange DetectedUI updates include a new Show glossary option and explanations of the color-coded change highlights (green for additions and red for deletions) with a new revision tag (v3.4.0) visible on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check42 days agoChange DetectedA new revision entry (v3.3.4) was added to the history and the previous revision (v3.3.3) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision: v3.3.3 was added to the record history and 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed from the footer. These updates affect metadata and footer content rather than study details or workflows.SummaryDifference0.2%

- Check92 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.2.0 in the Record History section. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page.